logo

Apellis Pharmaceuticals Inc (APLS) Stock: Navigating Market Highs and Lows in 52 Weeks

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Apellis Pharmaceuticals Inc’s current trading price is -49.51% away from its 52-week high, while its distance from the 52-week low is 141.25%. The stock’s price range during this period has varied between $19.83 and $94.75. The company, active in the Healthcare sector, saw a trading volume of around 1.34 million for the day, considerably higher average daily volume of 1.32 million observed over the last three months.

Apellis Pharmaceuticals Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $94.75 on 06/14/23, and the lowest price during the same period was recorded at $19.83 on 08/07/23.

How Financial Performance Impacts Market Capitalization

Apellis Pharmaceuticals Inc (APLS) has experienced a quarterly decline of -26.81% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.77B and boasts a workforce of 706 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 60.55, with a change in price of -16.03. Similarly, Apellis Pharmaceuticals Inc recorded 1,724,582 in trading volume during the last 100 days, posting a change of -25.10%.

How APLS’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for APLS stands at 0.57. Similarly, the long-term debt-to-equity ratio is also 0.54.

APLS Stock Stochastic Average

As of today, the raw stochastic average of Apellis Pharmaceuticals Inc over the past 50 days is 5.65%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 11.89%. Additionally, the Stochastic %K and %D values for the company were 16.28% and 18.50%, respectively, over the past 20 days.

APLS Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -20.08%.However, over the last six months, we can see a stronger performance of -1.26%. Over the last 30 days, the price of APLS has leaped by -18.61%. And in the last five days, it has surged by 0.42%.

Most Popular